"Trade Barriers and Antimicrobial Resistance." Donald H. Regan, co-author. (Work in Progress).
"The Orphan Drug Act at 35: Observations and Outlook for the 21st Century." Amitabh Chandra et al., co-authors. (Work in Progress).
"The Procedure Fetish."
Mich. L. Rev. 118 (Forthcoming).
Full Text:
SSRN
"Scientific Trials-In the Laboratories, Not the Courts." A. Carroll and P. A. Cohen, co-authors.
JAMA Internal Med. 178, no. 1 (2018): 7-8.
Full Text:
MLaw Repository |
WWW"Reform at Risk — Mandating Participation in Alternative Payment Plans." Scott Levy and Rahul Rajkumar, co-authors.
New Eng. J. Med. 378, no. 18 (2018): 1663-5.
Full Text:
MLaw Repository |
WWW"Limiting State Flexibility in Drug Pricing." Rachel E. Sachs, co-author.
New Eng. J. Med. 379, no. 11 (2018): 1002-4.
Full Text:
MLaw Repository |
WWW"Innovative Contracting for Pharmaceuticals and Medicaid's Best-Price Rule." Rachel Sachs and Darius N. Lakdawalla, co-authors.
J. Health Pol. Pol'y & L. 43, no. 1 (2018): 5-18.
Full Text:
SSRN |
WWWHealth Care Law and Ethics. 9th ed. Mark A. Hall et al., co-authors. Aspen Casebook Series. Alphen aan den Rijn, The Netherlands: Wolters Kluwer, 2018.
"Are Medicaid Work Requirements Legal?"
JAMA 319, no. 8 (2018): 763-4.
Full Text:
MLaw Repository |
WWW"Small Change, Big Consequences — Partial Medicaid Expansions under the ACA." Adrianna McIntyre and Allan M. Joseph, co-authors. New Eng. J. Med. 377, no. 11 (2017): 1004-6.
Full Text:
MLaw Repository |
WWW"Trouble on the Exchanges -Does the United States Owe Billions to Health Insurers?"
New Eng. J. Med. 375, no. 21 (2016): 2017-19.
Full Text: ProQuest (UMich users) |
ProQuest